Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

A third drug, pretomanid, received emergency authorization ... The goal was to improve treatment for patients with ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Tuberculosis spreads through germs released when a person with TB in their lungs coughs, speaks or sings. These bacteria can ...

For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment ...

A third drug, pretomanid ... The goal was to improve treatment for patients with tuberculosis resistant to rifampin. The WHO estimates that some 410,000 people become sick with rifampin-resistant ...